§ 13F · FUND PROFILE
Bain Capital Life Sciences Investors, LLC.
AUM · $1.7B (13F)Positions · 21Turnover · n/a · Q2Filed · Aug 14, 2026
CONCENTRATION
n/a
Top 10 holdings
NEW BUYS
0
+$558M deployed
EXITS
0
No exits
SECTOR SHIFT
n/a
No prior quarter data
§ 01 · TOP HOLDINGS
The book · Q2 2026
FILED AUG 14, 2026
| # | Ticker | Name | Shares | $ value | % port | Δ Q2 |
|---|---|---|---|---|---|---|
| 1 | KLRA | KAILERA THERAPEUTICS INC | 22.58M | $498M | 29.6% | NEW |
| 2 | HTFL | HEARTFLOW INC | 8.45M | $248M | 14.7% | −19% |
| 3 | NAMS | NEWAMSTERDAM PHARMA COMPANY | 3.81M | $129M | 7.7% | −48% |
| 4 | SVRA | SAVARA INC | 17.60M | $108M | 6.4% | ±0% |
| 5 | ALKS | ALKERMES PLC | 1.94M | $102M | 6.0% | +218% |
| 6 | SLDB | SOLID BIOSCIENCES INC | 9.81M | $98M | 5.8% | ±0% |
| 7 | PHVS | PHARVARIS N V | 2.68M | $93M | 5.5% | ±0% |
| 8 | OLMA | OLEMA PHARMACEUTICALS INC | 7.09M | $89M | 5.3% | −5% |
| 9 | COAG | HEMAB THERAPEUTICS HOLDINGS INC | 1.65M | $61M | 3.6% | NEW |
| 10 | CABA | CABALETTA BIO INC | 17.24M | $54M | 3.2% | +78% |
§ 02 · SECTOR ALLOCATION
Where the money is
Sector data pending
§ 03 · THE BAIN SIGNAL
AC read
Bain Capital Life Sciences Investors, LLC is a Other fund managing $1.7 billion in assets. The fund runs a focused portfolio of just 21 positions.
Read the full dossier →